All cancer types
Open
Phase 1/2
This study is looking at a drug called T3P-Y058-739 (T3P) for solid cancers.
A solid cancer is any cancer apart from a blood cancer such as leukaemia, lymphoma and myeloma.
Recruitment start: 2 June 2022
Recruitment end: 28 February 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kevin Harrington
T3 Pharmaceuticals AG
IQVA BIOTECH
Last reviewed: 14 October 2024
CRUK internal database number: 18049
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
